A Style Rave Originated Content. Visit for more rave-worthy fashion, beauty, lifestyle and culture news. Depression is an isolating and demanding experience that often creates the illusion of facing ...

The founder of the iconic Fort Myers Beach island resort, Lani Kai, died on Wednesday evening surrounded by his family.

Never forget that you are a valuable woman, recognize yourself as successful, loving, and hardworking. Here are 10 self-love ...

Real-time financial market data API, real-time forex data API, real-time stock data API, real-time cryptocurrency data API, real-time commodity data API service,real-time tick data,tick-by-tick quotes ...

Rajpal Yadav shares his thoughts on Atlee's 'Baby John' and how its poor performance has impacted Varun Dhawan. He praises Varun's versatility and compares his career to Shah Rukh Khan's ...

Depression in older adults, also called geriatric depression, is a mental and emotional disorder affecting older adults. Feelings of sadness and occasional “blue” moods are normal. However ...

The study failed to achieve its primary endpoint – treatment with the drug failed to demonstrate a significant improvement over placebo in alleviating depression symptoms, as measured by the ...

We’re back with news, including Merck’s decision to cut the price of its diabetes drug Januvia by 42% and Neumora’s readout on its experimental depression drug. Also, is the best way to ...

Neumora Therapeutics said a study of major depressive disorder treatment navacaprant didn't demonstrate a statistically significant improvement. Shares dived 79% to $2.20 after trading resumed ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, fell short of expectations in a late-stage clinical trial ...

Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...

A new depression treatment developed by startup Neumora Therapeutics failed in a Phase 3 clinical trial — the company’s first late-stage readout. The drug, navacaprant, failed to show a ...